Background Chronic red blood cell transfusion is the first-line treatment for severe forms of
thalassaemia. This therapy is, however, hampered by a number of adverse effects, including …

BACKGROUND: Identification of blood group antigen frequencies in a population has
various benefits in transfusion medicine. Most data in the literature include frequencies of …

Large scale red blood cell (RBC) antigen genotyping of donors is currently well developed.
There is scarce information, however, to select patients who might benefit from preemptive …

Background: The development of anti-red blood cell antibodies (both allo-and
autoantibodies) remains a major problem in thalassemia major patients. We studied the …

One of transfusion's side effects is alloimmunization against red blood cell (RBC) antigens.
Early diagnosis by antibody screening is an important step in the detection of these …

Background Knowledge about the frequency of red blood cell-antigen phenotypes in a
population can be helpful in the creation of a donor data bank for the preparation of …

Background: Thalassemia is one of the most common monogenic disorders characterized
by reduced production of globin chains. Although regular red blood cell (RBC) transfusion …

BACKGROUND Hemoglobin E‐β0 thalassemia and homozygous β0‐thalassemia are the
most common chronic transfusion‐dependent thalassemias in Thailand. Patients with these …

BACKGROUND β‐Thalassemia is considered the most common chronic hemolytic anemia
in Egypt. Alloimmunization can lead to serious clinical complications in transfusion …

BACKGROUND β‐Thalassemia is a common hemoglobinopathy in the Arabian Peninsula.
Red blood cell (RBC) transfusion is a cornerstone for its management, but can create …